AzTrials
AzTrials

HealthyNCT03447561

The Role of Consumption and Anticipation in Dopamine Release to Food Reward

A study testing Anticipatory + consummatory food reward and Consummatory food reward in people with Healthy and Food Reward, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to disentangle the relative contribution of the anticipatory (food images) versus consummatory (food administration) component of dopamine release to food reward, by performing simultaneous Positron Emission Tomography (PET) and Magnetic Resonance (MR) scanning. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Healthy, Food Reward
What is being tested?
Anticipatory + consummatory food reward and Consummatory food reward
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteBelgium
Study dates
8 Feb 2018to Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy females (on hormonal contraception)
  • Dutch-speaking
  • Right-handed
  • Stable body weight with Body Mass Index (BMI) of 18.5 - 25 kg/m^2

Who cannot join

  • Medical, neurological or psychiatric disorders
  • Use of psychotropic medication in past 6 months
  • Use of cannabis or other drugs of abuse in past 12 months
  • Lactose-intolerance or food allergies
  • Vegetarian diet
  • Smoking
Show all 11Show fewer
  • Consumption of more than 7 alcoholic units per week
  • Exposure to a significant amount of ionizing radiation in past 12 months
  • Claustrophobia
  • Contra-indications for Magnetic Resonance Imaging
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

Lukas Van Oudenhove, Prof. dr. contact

003216330147

lukas.vanoudenhove@kuleuven.be

Danielle Jongen, Msc contact

003216376200

danielle.jongen@kuleuven.be

Belgium1 site, 1 recruiting
  • Universitaire ziekenhuizen Leuven

    Leuven, 3000

    Recruiting

Other trials in Belgium

About this study

Official title: The Role of Consumption and Anticipation in Dopamine Release to Food Reward: an [18F]-Fallypride PET/MR Study.

This study aims to disentangle the relative contribution of the anticipatory (food images) versus consummatory (food administration) component of dopamine release to food reward, by performing simultaneous Positron Emission Tomography (PET) and Magnetic Resonance (MR) scanning. Additionally, this study aims to assess the relationship of the dopamine release with (changes in) metabolic hormone levels.

Read the detailed description

The brain's reward system has a potent contribution to the regulation of food intake. Although animal work has demonstrated a key role of the mesolimbic dopamine system in food reward responses, evidence in humans is still sparse and inconsistent. Our research group recently used state-of-the-art Positron Emission Tomography (PET) imaging methods to study in vivo dopamine release in response to a combination of anticipatory (viewing high-calorie food images) and consummatory (drinking sips of chocolate milkshake) food stimuli in healthy women. The investigators demonstrated dopamine release in reward-related regions in the prefrontal cortex of the brain in response to these stimuli, correlating with levels of gastrointestinal hunger/satiety hormones, and predicting subsequent food intake.

The current study aims to disentangle the relative contribution of the anticipatory (food images) versus consummatory (food administration) component of dopamine release to food reward, by performing simultaneous Positron Emission Tomography (PET) and Magnetic Resonance (MR) scanning. Healthy females will participate in two PET-MR scan sessions in a fasted state: one session with the combination of anticipatory (viewing high-calorie food images) and consummatory reward (drinking sips of chocolate milkshake) and one session with purely consummatory reward. The order of these sessions will be randomized and counterbalanced.

Both scan sessions will consist of four blocks with a duration of 45 minutes each and 15 minute breaks in between. The first three blocks represent the 'control condition' and the fourth block the 'food reward condition'. At the end of each scan session, participants will take part in an ad libitum drink test in which they will be instructed to drink as much chocolate milkshake as preferred, until comfortably full. During both sessions, blood samples will be collected at several time points to assess levels of metabolic hormones and their relation to food-induced dopamine release. The proposed studies aims to increase our understanding of the psycho-biology of appetite and food intake regulation as well as identify potential new treatment targets for disorders of food intake, both at the level of the gastrointestinal tract and the brain.

Conditions
Healthy, Food Reward
Being tested
Anticipatory + consummatory food reward, Consummatory food reward
Keywords
Dopamine, Food, Reward, Anticipatory, Consummatory, Positron Emission Tomography, Magnetic Resonance, Metabolic hormones

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anticipatory + consummatory food rewardBehavioural

    Exposure to a combination of anticipatory (viewing high-calorie food images) and consummatory food reward (drinking sips of chocolate milkshake).

  • Consummatory food rewardBehavioural

    Exposure to consummatory food reward (drinking sips of chocolate milkshake).

Study groups in NCT03447561
Study groupRoleWhat they receive
Anticipatory + consummatory food rewardExperimentalPET-MR scan session with a combination of anticipatory (viewing high-calorie food images) and consummatory food reward (drinking sips of chocolate milkshake). This scan session will consist of four blocks with a duration of 45 minutes each and 15 minute breaks in between. The first three blocks represent the 'control condition' (viewing neutral images and drinking sips of water) and the fourth block the 'food reward condition' (viewing high-calorie food images and drinking sips of chocolate milkshake).
Receives: Behavioral: Anticipatory + consummatory food reward
Consummatory food rewardExperimentalPET-MR scan session with purely consummatory food reward (drinking sips of chocolate milkshake). This scan session will consist of four blocks with a duration of 45 minutes each and 15 minute breaks in between. The first three blocks represent the 'control condition' (drinking sips of water) and the fourth block the 'food reward condition' (drinking sips of chocolate milkshake).
Receives: Behavioral: Consummatory food reward

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dopamine release to combined vs consummatory food reward

    Changes in [18F]-Fallypride binding potential (reflecting dopamine release) in the food reward condition

    Measured: Continuously over 225 minutes after onset scanning

Secondary outcomes (3)
  1. Composite measure of Metabolic hormone levels

    Correlation between dopamine response to food reward and (changes in) metabolic hormone levels (ghrelin, motilin, glucagon-like peptide 1, peptide tyrosine tyrosine, leptin, and insulin).

    Measured: 5 minutes before onset scanning and 45, 105, 165, 180, 195, 210 and 225 minutes after onset scanning

  2. Amount of milkshake consumed during drink test

    Correlation between dopamine response to food reward and the amount of milkshake consumed during the drink test

    Measured: 230 minutes after onset of scanning (immediately following end of scanning)

  3. Temperament and Character Inventory questionnaire

    Correlation between dopamine response to food reward and scores on the Temperament and Character Inventory questionnaire.

    Measured: baseline, dopamine release measured 225 minutes following onset scanning

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2018
  2. Study start8 Feb 2018
  3. Primary completionJun 2019 (estimated)
  4. Study completionJun 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
All participants will receive one PETMR scan session with the combination of anticipatory (viewing high-calorie food images) and consummatory reward (drinking sips of chocolate milkshake), and one PETMR scan session with purely consummatory reward, in a randomized and counterbalanced order.
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03447561
Sponsor's protocol ID
S60362-h
Status last verified
Feb 2018
First submitted
8 Feb 2018
Last updated
27 Feb 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Anticipatory + consummatory food reward and Consummatory food reward in people with Healthy and Food Reward, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lukas Van Oudenhove, Prof. dr. (003216330147, lukas.vanoudenhove@kuleuven.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dopamine release to combined vs consummatory food reward (time frame: Continuously over 225 minutes after onset scanning). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in